Dynorphins in Development and Disease: Implications for Cardiovascular Disease

Area of Science:

• Cardiovascular Physiology
• Neuropharmacology
• Intracrine Signaling Networks

Background:

• Cardiovascular disease (CVD) is a growing global health concern.
• Intracrine signaling pathways, including opioid involvement, are crucial for cardiovascular homeostasis.
• Dynorphin's role in cardiovascular and cerebrovascular regulation is complex and not fully understood.

Purpose of the Study:

• To review high-impact publications on intracrine opioid signaling in cardiovascular health and disease.
• To elucidate the specific roles of dynorphin in cardiovascular and cerebrovascular processes.
• To explore the therapeutic potential of targeting the kappa-opioid receptor for CVD prevention.

Main Methods:

• Comprehensive literature review of past and recent studies.
• Analysis of research on opioid effects on heart function, ischemia, reperfusion, and blood flow.
• Focus on dynorphin's involvement in cerebrovascular and cardiovascular regulation and inflammation.

Main Results:

• Opioids, especially dynorphin, influence diverse cardiovascular and cerebrovascular functions.
• Paradoxical findings highlight the complexity of dynorphin's role, suggesting cross-talk with other signaling networks.
• Dynorphin is implicated in cardiovascular-related inflammation.

Conclusions:

• Dynorphin-mediated signaling is critical for cardiovascular and cerebrovascular regulation, despite complex and sometimes disputed effects.
• Targeting the kappa-opioid receptor (a key dynorphin receptor) with inhibitors may offer a novel strategy for managing cardiovascular diseases.
• Further research is needed to fully unravel dynorphin's intricate roles and therapeutic potential in cardiovascular medicine.